FIELD: biotechnology and genetic engineering.
SUBSTANCE: inventions group relates to the field of biotechnology and genetic engineering. Described is a recombinant virus-like particle for inducing specific immunity against the severe acute respiratory syndrome virus SARS-CoV-2, containing recombinant E, M, N coronavirus proteins and one or more S proteins of various coronavirus strains, containing the nucleotide sequences of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, which are obtained in a baculovirus insect expression system, while the virus-like particle mimics the SARS-virion CoV-2. Also disclosed is a method for producing a recombinant virus-like particle. And a recombinant baculovirus is claimed to produce a recombinant virus-like particle, comprising a gene selected from the group: a gene encoding a coronavirus E protein having the nucleotide sequence of SEQ ID NO:1, a gene encoding a coronavirus M protein having the nucleotide sequence of SEQ ID NO:2, a gene, encoding the coronavirus N protein having the nucleotide sequence of SEQ ID NO:3, a gene encoding the coronavirus S protein having the nucleotide sequence of SEQ ID NO:4, a gene encoding the coronavirus S protein having the nucleotide sequence of SEQ ID NO:5, a gene encoding the coronavirus S protein having the nucleotide sequence of SEQ ID NO:6; a gene encoding the coronavirus S protein having the nucleotide sequence of SEQ ID NO:7.
EFFECT: inventions group provides for obtaining stable virus-like particles containing actual antigens of the SARS-CoV-2 coronavirus, which are capable of self-assembling in insect cells that mimic the coronavirus virion and are capable of inducing a specific immune response against the severe acute respiratory syndrome virus SARS-CoV-2.
7 cl, 7 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VIRUS-LIKE CHIMERIC PARTICLES FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 CONTAINING CORONAVIRUS AND ROTAVIRUS PROTEINS | 2022 |
|
RU2779810C1 |
| IMMUNOBIOLOGICAL AGENT BASED ON VIRUS-LIKE PARTICLES FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST INFECTION CAUSED BY HUMAN ROTAVIRUS A | 2022 |
|
RU2795055C1 |
| PRODUCTION OF VIRUS-LIKE PARTICLES IN PLANTS | 2011 |
|
RU2655431C2 |
| ARTIFICIAL GENE CODING A BICISTRONIC STRUCTURE FORMED BY RECEPTOR-BINDING DOMAIN SEQUENCES OF THE GLYCOPROTEIN S OF THE SARS-COV-2 CORONAVIRUS, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS | 2020 |
|
RU2733831C1 |
| ARTIFICIAL GENE STBL_RBD_TRM_SC2, CODING A BICISTRONIC STRUCTURE FORMED BY THE SARS-COV-2 CORONAVIRUS GLYCOPROTEIN S RECEPTOR-BINDING DOMAIN SEQUENCES, TRANSMEMBRANE REGION, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_TRM_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_TRM_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS | 2020 |
|
RU2733832C1 |
| ISOLATED RECOMBINANT VIRUS BASED ON INFLUENZA VIRUS FOR INDUCING SPECIFIC IMMUNITY TO INFLUENZA VIRUS AND/OR PREVENTING DISEASES CAUSED BY INFLUENZA VIRUS | 2021 |
|
RU2813150C2 |
| EFFECTIVE INFLUENZA VLPS | 2004 |
|
RU2369405C2 |
| VIRUS-LIKE PARTICLES (VLP) OF RABIES VIRUS GLYCOPROTEIN | 2011 |
|
RU2575800C2 |
| METHOD OF OBTAINING A RECOMBINANT VACCINE FOR PREVENTION OF HUMANPAPILLOMA VIRUS INFECTION, RECOMBINANT VACCINE | 2018 |
|
RU2681174C1 |
| PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS | 2020 |
|
RU2743593C1 |
